NCT06829446View on ClinicalTrials.gov

Recurrent Persistent Atrial Fibrillation:In-situ Ablation Vs Extensive Ablation

NACompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions
Recurrent Persistent Atrial Fibrillation
Interventions
PROCEDURE

Extra-PV extensive ablation

Extra-PV extensive ablation

PROCEDURE

Repeat same PVI and linear ablation as the first procedure

Repeat same PVI and linear ablation as the first procedure

Trial Locations (1)

Unknown

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
collaborator

Jinshan Hospital Affiliated to Fudan University

UNKNOWN

collaborator

Tongji University

OTHER

lead

Shanghai Chest Hospital

OTHER

NCT06829446 - Recurrent Persistent Atrial Fibrillation:In-situ Ablation Vs Extensive Ablation | Biotech Hunter | Biotech Hunter